Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An inspiring doctor and scientist of great compassion and intellect, Sir David Weatherall died 8 Dec 2018. A Nuffield Professor of Medicine, founder of the MRC Weatherall Institute of Molecular Medicine and a member of Wellcome’s Board throughout the 1990s, Sir David was instrumental in the creation of MORU back in 1979.

David Weatherall © Credit: University of Exeter CC BY 2.0

Personal Note from Nick White, SE Asia Chairman, MORU Tropical Network

Professor David Weatherall had the greatest influence on my professional life and for that I will be eternally grateful. I went to work for him as a young medical registrar at the Radcliffe Infirmary in Oxford in November 1977 (Tim Peto was my houseman!). Before I went to Oxford I had never heard of him – a reflection of my ignorance as he was already recognised as a brilliant scientist and an emerging leader in British academic medicine. I first met him (we all called him “Prof”) in his book lined office with old leathery chairs and a thick haze of aromatic pipe smoke. I said I wanted to work in the tropics one day, and he told me that he too was interested in tropical medicine and, if possible, would make it happen. He certainly did, and that is why we have a 40 year medical research collaboration based in Thailand and a younger unit in Vietnam.

“Prof” was a brilliant scientist and a perceptive, wise, witty, gentle, compassionate and inspiring physician. He would always enquire about his patient’s social circumstances, and he always examined them. This was an era when senior physicians and surgeons often felt and acted as if they were on a higher plane than the remainder of humanity. David Weatherall hated all that pomp and flummery. He treated everyone as equals. He had a sharp wit, an open and enquiring mind, and he took genuine satisfaction and pride in the success of others. “Prof” inspired and supported a generation of young physicians and scientists. He became the UK’s leading academic clinician, a towering figure in the molecular medicine revolution, an internationally acclaimed scientist, and he was showered with honours and accolades – but his character never changed.

In the late 1970s the Wellcome Trust were seeking to set up a new tropical medicine research unit in East Asia. David Weatherall and Peter Williams (then the Director of the Wellcome Trust) visited several potential collaborating institutions. The Faculty of Tropical Medicine, Mahidol University were interested in this idea and so the Bangkok unit began in 1979 as a collaboration between the Faculty and the Nuffield Department of Medicine, Oxford University headed by David Weatherall. David and Mary Warrell came out to start the research work and I joined them the following year. “Prof” supported us through good times and bad, and although we were successful on the scientific front there were bad times too. We came under a lot of pressure in the late 1980s and I thought we might have to close the Unit and leave Thailand. This led to the founding of the Vietnam unit. David Weatherall in Oxford and Bridget Ogilvie at the Wellcome Trust gave us unwavering support throughout those hard times. Without that we would not have MORU today.

I kept “Prof” up to date with everything that happened in our Unit, and our research progress because he was always interested and encouraging, and he invariably gave wise advice. For such a brilliant mind he was interestingly averse to communications technology – he never mastered computers or e-mail, preferring written letters and personal meetings. As far as I know he never possessed a mobile ‘phone! In scientific and clinical meetings, he would close his eyes, and appear to be completely asleep, but as soon as the speaker stopped he would open his eyes and ask pertinent questions! He was a determined pipe smoker – and on two occasions I witnessed smoke billowing from the pocket of his white coat! Long after he retired I would visit him whenever I was in Oxford to report as he wanted to know how we in MORU were getting on, what advances we had made, and whether there was anything he could do to help. He had a great affection for Thailand, sharing research interests on the study and management of haemoglobinopathies, collaborating with leading figures in Thai medical research, and later advising the Prince Mahidol Award foundation. He was very happy to see the research progress, and particularly the translation to human benefit, and also the career progression of young investigators from Thailand and neighbouring countries. We certainly owe him a lot.

He was a very great man.

Read Sir David’s recollections of how MORU came about (pdf)

Read the News "Sir David Weatherall, 1933-2018" on the Wellcome website

Read what the University of Oxford says about Sir David’s remarkable career.

Similar stories

FORESFA and VIE project meetings

The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.

A multi-country study of monkeypox being launched – first cases enrolled in Geneva

Researchers have launched a new study to improve our understanding of monkeypox disease. The first patients have now been recruited at Hôpitaux Universitaires de Genève (HUG) in Switzerland

Pandemic Sciences Institute formally launched in Oxford

The University of Oxford’s Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.The PSI will draw together academics and experts from across the University to build a multi-disciplinary institute focused on reducing the risk from infectious threats through science, innovation and building global preparedness.

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.